The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Parathyroid Hormone Analog Market Research Report 2025
Synopsis
The global Parathyroid Hormone Analog market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Parathyroid Hormone Analog is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parathyroid Hormone Analog is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Parathyroid Hormone Analog include Pfizer, Abbott Laboratories, Merck, Natpara, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly, Cell Genesys Inc and OSI Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Parathyroid Hormone Analog, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parathyroid Hormone Analog.
Report Scope
The Parathyroid Hormone Analog market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parathyroid Hormone Analog market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parathyroid Hormone Analog manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Abbott Laboratories
Merck
Natpara
GlaxoSmithKline Plc
Sanofi SA
Eli Lilly
Cell Genesys Inc
OSI Pharmaceuticals
Paladin Labs Inc
ALZA Corporation
Segment by Type
Abaloparatide
Teriparatide
Human Parathyroid Hormone Recombinant
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parathyroid Hormone Analog manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parathyroid Hormone Analog in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Parathyroid Hormone Analog market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Parathyroid Hormone Analog is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parathyroid Hormone Analog is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Parathyroid Hormone Analog include Pfizer, Abbott Laboratories, Merck, Natpara, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly, Cell Genesys Inc and OSI Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Parathyroid Hormone Analog, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parathyroid Hormone Analog.
Report Scope
The Parathyroid Hormone Analog market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parathyroid Hormone Analog market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parathyroid Hormone Analog manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Abbott Laboratories
Merck
Natpara
GlaxoSmithKline Plc
Sanofi SA
Eli Lilly
Cell Genesys Inc
OSI Pharmaceuticals
Paladin Labs Inc
ALZA Corporation
Segment by Type
Abaloparatide
Teriparatide
Human Parathyroid Hormone Recombinant
Segment by Application
Hospitals
Clinics
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parathyroid Hormone Analog manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parathyroid Hormone Analog in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Parathyroid Hormone Analog Market Overview
1.1 Product Overview and Scope of Parathyroid Hormone Analog
1.2 Parathyroid Hormone Analog Segment by Type
1.2.1 Global Parathyroid Hormone Analog Market Value Comparison by Type (2024-2030)
1.2.2 Abaloparatide
1.2.3 Teriparatide
1.2.4 Human Parathyroid Hormone Recombinant
1.3 Parathyroid Hormone Analog Segment by Application
1.3.1 Global Parathyroid Hormone Analog Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Parathyroid Hormone Analog Market Size Estimates and Forecasts
1.4.1 Global Parathyroid Hormone Analog Revenue 2019-2030
1.4.2 Global Parathyroid Hormone Analog Sales 2019-2030
1.4.3 Global Parathyroid Hormone Analog Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Parathyroid Hormone Analog Market Competition by Manufacturers
2.1 Global Parathyroid Hormone Analog Sales Market Share by Manufacturers (2019-2024)
2.2 Global Parathyroid Hormone Analog Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Parathyroid Hormone Analog Average Price by Manufacturers (2019-2024)
2.4 Global Parathyroid Hormone Analog Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parathyroid Hormone Analog, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parathyroid Hormone Analog, Product Type & Application
2.7 Parathyroid Hormone Analog Market Competitive Situation and Trends
2.7.1 Parathyroid Hormone Analog Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parathyroid Hormone Analog Players Market Share by Revenue
2.7.3 Global Parathyroid Hormone Analog Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parathyroid Hormone Analog Retrospective Market Scenario by Region
3.1 Global Parathyroid Hormone Analog Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Parathyroid Hormone Analog Global Parathyroid Hormone Analog Sales by Region: 2019-2030
3.2.1 Global Parathyroid Hormone Analog Sales by Region: 2019-2024
3.2.2 Global Parathyroid Hormone Analog Sales by Region: 2025-2030
3.3 Global Parathyroid Hormone Analog Global Parathyroid Hormone Analog Revenue by Region: 2019-2030
3.3.1 Global Parathyroid Hormone Analog Revenue by Region: 2019-2024
3.3.2 Global Parathyroid Hormone Analog Revenue by Region: 2025-2030
3.4 North America Parathyroid Hormone Analog Market Facts & Figures by Country
3.4.1 North America Parathyroid Hormone Analog Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Parathyroid Hormone Analog Sales by Country (2019-2030)
3.4.3 North America Parathyroid Hormone Analog Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Parathyroid Hormone Analog Market Facts & Figures by Country
3.5.1 Europe Parathyroid Hormone Analog Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Parathyroid Hormone Analog Sales by Country (2019-2030)
3.5.3 Europe Parathyroid Hormone Analog Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parathyroid Hormone Analog Market Facts & Figures by Country
3.6.1 Asia Pacific Parathyroid Hormone Analog Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Parathyroid Hormone Analog Sales by Country (2019-2030)
3.6.3 Asia Pacific Parathyroid Hormone Analog Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Parathyroid Hormone Analog Market Facts & Figures by Country
3.7.1 Latin America Parathyroid Hormone Analog Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Parathyroid Hormone Analog Sales by Country (2019-2030)
3.7.3 Latin America Parathyroid Hormone Analog Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parathyroid Hormone Analog Market Facts & Figures by Country
3.8.1 Middle East and Africa Parathyroid Hormone Analog Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Parathyroid Hormone Analog Sales by Country (2019-2030)
3.8.3 Middle East and Africa Parathyroid Hormone Analog Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parathyroid Hormone Analog Sales by Type (2019-2030)
4.1.1 Global Parathyroid Hormone Analog Sales by Type (2019-2024)
4.1.2 Global Parathyroid Hormone Analog Sales by Type (2025-2030)
4.1.3 Global Parathyroid Hormone Analog Sales Market Share by Type (2019-2030)
4.2 Global Parathyroid Hormone Analog Revenue by Type (2019-2030)
4.2.1 Global Parathyroid Hormone Analog Revenue by Type (2019-2024)
4.2.2 Global Parathyroid Hormone Analog Revenue by Type (2025-2030)
4.2.3 Global Parathyroid Hormone Analog Revenue Market Share by Type (2019-2030)
4.3 Global Parathyroid Hormone Analog Price by Type (2019-2030)
5 Segment by Application
5.1 Global Parathyroid Hormone Analog Sales by Application (2019-2030)
5.1.1 Global Parathyroid Hormone Analog Sales by Application (2019-2024)
5.1.2 Global Parathyroid Hormone Analog Sales by Application (2025-2030)
5.1.3 Global Parathyroid Hormone Analog Sales Market Share by Application (2019-2030)
5.2 Global Parathyroid Hormone Analog Revenue by Application (2019-2030)
5.2.1 Global Parathyroid Hormone Analog Revenue by Application (2019-2024)
5.2.2 Global Parathyroid Hormone Analog Revenue by Application (2025-2030)
5.2.3 Global Parathyroid Hormone Analog Revenue Market Share by Application (2019-2030)
5.3 Global Parathyroid Hormone Analog Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Parathyroid Hormone Analog Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Parathyroid Hormone Analog Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Parathyroid Hormone Analog Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Natpara
6.4.1 Natpara Corporation Information
6.4.2 Natpara Description and Business Overview
6.4.3 Natpara Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Natpara Parathyroid Hormone Analog Product Portfolio
6.4.5 Natpara Recent Developments/Updates
6.5 GlaxoSmithKline Plc
6.5.1 GlaxoSmithKline Plc Corporation Information
6.5.2 GlaxoSmithKline Plc Description and Business Overview
6.5.3 GlaxoSmithKline Plc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Plc Parathyroid Hormone Analog Product Portfolio
6.5.5 GlaxoSmithKline Plc Recent Developments/Updates
6.6 Sanofi SA
6.6.1 Sanofi SA Corporation Information
6.6.2 Sanofi SA Description and Business Overview
6.6.3 Sanofi SA Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi SA Parathyroid Hormone Analog Product Portfolio
6.6.5 Sanofi SA Recent Developments/Updates
6.7 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Parathyroid Hormone Analog Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 Cell Genesys Inc
6.8.1 Cell Genesys Inc Corporation Information
6.8.2 Cell Genesys Inc Description and Business Overview
6.8.3 Cell Genesys Inc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cell Genesys Inc Parathyroid Hormone Analog Product Portfolio
6.8.5 Cell Genesys Inc Recent Developments/Updates
6.9 OSI Pharmaceuticals
6.9.1 OSI Pharmaceuticals Corporation Information
6.9.2 OSI Pharmaceuticals Description and Business Overview
6.9.3 OSI Pharmaceuticals Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.9.4 OSI Pharmaceuticals Parathyroid Hormone Analog Product Portfolio
6.9.5 OSI Pharmaceuticals Recent Developments/Updates
6.10 Paladin Labs Inc
6.10.1 Paladin Labs Inc Corporation Information
6.10.2 Paladin Labs Inc Description and Business Overview
6.10.3 Paladin Labs Inc Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Paladin Labs Inc Parathyroid Hormone Analog Product Portfolio
6.10.5 Paladin Labs Inc Recent Developments/Updates
6.11 ALZA Corporation
6.11.1 ALZA Corporation Corporation Information
6.11.2 ALZA Corporation Parathyroid Hormone Analog Description and Business Overview
6.11.3 ALZA Corporation Parathyroid Hormone Analog Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ALZA Corporation Parathyroid Hormone Analog Product Portfolio
6.11.5 ALZA Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parathyroid Hormone Analog Industry Chain Analysis
7.2 Parathyroid Hormone Analog Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parathyroid Hormone Analog Production Mode & Process
7.4 Parathyroid Hormone Analog Sales and Marketing
7.4.1 Parathyroid Hormone Analog Sales Channels
7.4.2 Parathyroid Hormone Analog Distributors
7.5 Parathyroid Hormone Analog Customers
8 Parathyroid Hormone Analog Market Dynamics
8.1 Parathyroid Hormone Analog Industry Trends
8.2 Parathyroid Hormone Analog Market Drivers
8.3 Parathyroid Hormone Analog Market Challenges
8.4 Parathyroid Hormone Analog Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
